NASDAQ:IPSC

Century Therapeutics - IPSC News Today

$3.76

-0.18 (-4.57%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $3.73
▼
$3.99
50-Day Range: $3.66
▼
$5.11
52-Week Range: $3.54
▼
$14.00

Volume: 253,041 shs
Average Volume: 222,914 shs
Market Capitalization: $222.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $19.00

Institutional Ownership

Get Century Therapeutics News Delivered to You Automatically

IPSC Media Mentions By Week

IPSC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IPSC
News Sentiment
▼
0.23

0.34
▲
Average
Medical
News Sentiment

IPSC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IPSC Articles
This Week
▼
26

1
▲
IPSC Articles
Average Week

Source

Source	Headline
	Century Therapeutics, Inc. (NASDAQ:IPSC) to Post FY2024 Earnings of ($2.70) Per Share, HC Wainwright Forecasts marketbeat.com - March 20 at 2:28 AM
	HC Wainwright Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $17.00 marketbeat.com - March 17 at 7:41 AM
	Research Analysts Offer Predictions for Century Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:IPSC) americanbankingnews.com - March 22 at 3:18 AM
	Century Therapeutics, Inc. (NASDAQ:IPSC) Forecasted to Post Q1 2024 Earnings of ($0.48) Per Share americanbankingnews.com - March 22 at 2:33 AM
	Chardan Capital Sticks to Their Buy Rating for Century Therapeutics (IPSC) markets.businessinsider.com - March 21 at 9:47 PM
	Bank of America Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $20.00 americanbankingnews.com - March 21 at 2:58 AM
	Century Therapeutics's Return On Capital Employed Overview msn.com - March 20 at 12:44 PM
	HC Wainwright Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $17.00 americanbankingnews.com - March 20 at 5:38 AM
	Century Therapeutics (NASDAQ:IPSC) Earns "Buy" Rating from EF Hutton Acquisition Co. I americanbankingnews.com - March 19 at 6:56 AM
	EF Hutton Sticks to Their Buy Rating for Century Therapeutics (IPSC) markets.businessinsider.com - March 16 at 5:24 PM
	Century Therapeutics, Inc.: Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates finanznachrichten.de - March 16 at 12:24 PM
	Century Therapeutics GAAP EPS of -$2.27 beats by $0.05, revenue of $5.2M misses by $1.76M msn.com - March 16 at 12:24 PM
	Where Century Therapeutics Stands With Analysts markets.businessinsider.com - March 16 at 12:24 PM
	Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates finance.yahoo.com - March 16 at 12:24 PM
	Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com - March 16 at 12:24 PM
	Century Therapeutics to Present at the AACR Annual Meeting 2023 finance.yahoo.com - March 15 at 4:22 PM
	Brokerages Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $19.38 americanbankingnews.com - March 12 at 1:22 AM
	Century Therapeutics Stock (NASDAQ:IPSC), Analyst Ratings, Price Targets, Predictions benzinga.com - March 1 at 4:24 AM
	Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023 uk.finance.yahoo.com - February 20 at 6:16 PM
	Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas finance.yahoo.com - February 8 at 9:50 AM
	After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC) finance.yahoo.com - January 17 at 1:48 PM
	Century Therapeutics becomes latest life sciences company to enact layoffs, narrow focus finance.yahoo.com - January 9 at 12:30 PM
	8 Analysts Have This to Say About Century Therapeutics markets.businessinsider.com - January 6 at 3:28 PM
	Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive finance.yahoo.com - January 6 at 10:28 AM
	Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026 finance.yahoo.com - January 5 at 5:29 PM
	Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 4 at 10:18 AM
	Further weakness as Century Therapeutics (NASDAQ:IPSC) drops 12% this week, taking one-year losses to 39% finance.yahoo.com - December 8 at 6:33 PM
	Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference finance.yahoo.com - November 22 at 4:27 PM
	Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates finance.yahoo.com - November 11 at 9:44 AM
	Century Therapeutics, Inc.: Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates finanznachrichten.de - November 10 at 1:42 PM
	Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates finance.yahoo.com - November 10 at 1:42 PM
	Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 10 at 1:42 PM
	Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022 finance.yahoo.com - November 2 at 12:43 PM
	Century Therapeutics to Present at the SITC 37th Annual Meeting finance.yahoo.com - October 5 at 6:27 PM
	Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors finance.yahoo.com - October 3 at 7:53 AM
	Century Therapeutics to Present at Chardan's 6th Annual Genetic Medicines Conference benzinga.com - September 26 at 11:27 AM
	Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference finance.yahoo.com - September 26 at 11:27 AM
	Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - September 6 at 12:04 PM
	Century Therapeutics receives IND clearance for allogeneic cell therapy candidate seekingalpha.com - August 27 at 4:19 AM
	FDA Announced Clearance To Century Therapeutics' Allogeneic Cell Therapy Candidate Study markets.businessinsider.com - August 25 at 10:07 AM
	Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection finance.yahoo.com - August 25 at 10:07 AM
	Investors in Century Therapeutics (NASDAQ:IPSC) have unfortunately lost 62% over the last year nasdaq.com - August 15 at 10:23 PM
	Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates finance.yahoo.com - August 11 at 7:09 PM
	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com - August 11 at 7:09 PM
	Further weakness as Century Therapeutics (NASDAQ:IPSC) drops 13% this week, taking one-year losses to 71% finance.yahoo.com - July 1 at 11:44 AM
	Century Therapeutics joins Russell Microcap® Index seekingalpha.com - June 24 at 10:00 PM
	Century Therapeutics Announces Its Addition to the Russell Microcap® Index finance.yahoo.com - June 24 at 4:59 PM
	Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium finance.yahoo.com - June 21 at 8:22 PM
	Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022 finance.yahoo.com - June 6 at 1:32 PM
	Century Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates finance.yahoo.com - May 16 at 4:22 PM
	Century Therapeutics to Present at Upcoming Investor Conferences finance.yahoo.com - May 3 at 7:48 PM
	Century Therapeutics to Present at the ASGCT 25th Annual Meeting finance.yahoo.com - May 2 at 6:05 PM

Get Century Therapeutics News Delivered to You Automatically

This page (NASDAQ:IPSC) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Century Therapeutics - IPSC News Today

IPSC Media Mentions By Week

IPSC Media Sentiment

IPSC News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info